Comparative performance of lab tests and blood testing device to monitor glucose, total cholesterol and triacylglycerol in type 2 diabetic patients

Authors

  • Arnaldo Zubioli State University of Maringá; Department of Pharmacy and Pharmacology
  • Marcia Regina Batista State University of Maringá; Department of Clinical Analysis
  • Talitha Fernandes Stefanello State University of Maringá; Department of Clinical Analysis
  • Marcia Aparecida Carrara State University of Maringá; Department of Pharmacy and Pharmacology
  • Roberto Barbosa Bazotte State University of Maringá; Department of Pharmacy and Pharmacology

DOI:

https://doi.org/10.1590/S1984-82502011000300020

Keywords:

Laboratory tests, Glycated hemoglobin, Glycemia, Total cholesterol, Triacylglycerol, Type 2 diabetes

Abstract

The performance of lab tests (LT) and blood testing devices (BTD) to monitor glycemia vs. glycated hemoglobin A1c (A1c) were compared. In addition, the performance of blood glucose, total cholesterol (TC) and triacylglycerol measured by LT and BDT were compared. All parameters were measured based on the same blood samples from overnight fasted type 2 diabetic patients (T2DP). Linear regression analysis was used for all comparisons. The results showed that A1c correlated better with LT-glucose (r = 0.58) than BTD-glucose (r = 0.42). Moreover, LT vs. BTD showed r values of 0.90, 0.82 and 0.92 for glucose, TC and triacylglycerol, respectively. It was concluded that the performance of LT-glucose was better than BDT-glucose. Moreover, since triacylycerol and TC measured by BTD correlated better with LT compared to BDT-glucose vs. LT-glucose, the inclusion of BTD-TC and BTD-triacylglycerol for detecting and monitoring hyperlipidemia in T2DP should be considered.

Downloads

Download data is not yet available.

Downloads

Published

2011-09-01

Issue

Section

Articles

How to Cite

Comparative performance of lab tests and blood testing device to monitor glucose, total cholesterol and triacylglycerol in type 2 diabetic patients . (2011). Brazilian Journal of Pharmaceutical Sciences, 47(3), 615-621. https://doi.org/10.1590/S1984-82502011000300020